Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-011531
Filing Date
2025-04-29
Accepted
2025-04-29 18:30:29
Documents
1
Period of Report
2025-04-25

Document Format Files

Seq Description Document Type Size
1 form4-04292025_100425.html 4  
1 form4-04292025_100425.xml 4 3559
  Complete submission text file 0001415889-25-011531.txt   4951
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Issuer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1095 AVENUE OF THE AMERICAS, 8TH FLOOR NEW YORK NY 10036
Business Address
Stratton John G (Reporting) CIK: 0001385262 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-02189 | Film No.: 25890011